Chief Medical Officer of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Trehu Elizabeth, sells 2,452 shares worth $16,576
According to Jounce Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company Chief Medical Officer, Trehu Elizabeth disclosed selling 2,452 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $16,576 in total. As of Jan 07, Trehu Elizabeth now owns 74,181 shares in total worth about $542,263.11.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) Chief Medical Officer, Trehu Elizabeth, we have the following information:
- SEC Form 4 filing: Jan 08: Sold 2,846 shares at the rate of $7.00 per share. Total worth of this trade was $19,922. Total number of shares owned as of Jan 08 were 71,335
- SEC Form 4 filing: Aug 14: Sold 1,728 shares at the rate of $4.67 per share. Total worth of this trade was $8,070. Total number of shares owned as of Aug 14 were 76,633
- SEC Form 4 filing: Aug 17: Sold 454 shares at the rate of $4.86 per share. Total worth of this trade was $2,206. Total number of shares owned as of Aug 17 were 77,377
Posted by
George Daniels
on Monday January 11 2021, 9:47 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
